Star Combo Pharma Limited (ASX:S66)

Star Combo Pharma Revenue

Star Combo Pharma had revenue of 11.93M AUD in the half year ending December 31, 2025, a decrease of -2.47%. This brings the company's revenue in the last twelve months to 23.99M, down -18.76% year-over-year. In the fiscal year ending June 30, 2025, Star Combo Pharma had annual revenue of 27.81M with 6.89% growth.

• Revenue (ttm): 23.99M
• Revenue Growth: -18.76%
• P/S Ratio: 1.21
• Revenue / Employee: 799.81K
• Employees: 30
• Market Cap: 29.04M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2025	27.81M	1.79M	6.89%
Jun 30, 2024	26.02M	1.32M	5.34%
Jun 30, 2023	24.70M	1.74M	7.57%
Jun 30, 2022	22.96M	-4.01M	-14.86%
Jun 30, 2021	26.97M	-12.11M	-31.00%